ストックスクリーナーアプリを入手
3.78
0.00%
0.00
Eledon Pharmaceuticals Inc (ELDN) 最新ニュース
[S-3] Eledon Pharmaceuticals, Inc. Shelf Registration Statement - Stock Titan
SEC Form DEFA14A filed by Eledon Pharmaceuticals Inc. - Quantisnow
[ARS] Eledon Pharmaceuticals, Inc. SEC Filing - Stock Titan
Major share authorization increase on ballot in Eledon (NASDAQ: ELDN) 2026 proxy - Stock Titan
NewcelX Reports Financial Results for 2025 and Provides Shareholders with Update on Accelerated Development of Type 1 Diabetes Treatment in Collaboration with Eledon Pharmaceuticals in 2026 - The Manila Times
NewcelX and Eledon Pharmaceuticals Collaborate on NCEL-101 for Type 1 Diabetes, Reporting Strong Financial Position and Strategic Growth Plans - Quiver Quantitative
NewcelX Reports Financial Results for 2025 and Provides Shareholders With Update on Accelerated Development of Type 1 Diabetes Treatment in Collaboration With Eledon Pharmaceuticals in 2026 - 富途牛牛
EXCLUSIVE: NewcelX Eyes Accelerated 2026 Execution For Diabetes Drug - Sahm
Eledon Pharmaceuticals (ELDN) Price Target Decreased by 14.93% to 8.33 - MSN
We fact-checked the hype behind the Eledon Pharmaceuticals Type 1 diabetes treatment - Healthcare Brew
BlackRock (NYSE) reports 4.38M-share stake in Eledon (ELDN) - Stock Titan
Eledon Pharmaceuticals drops 10% on stock offering - MSN
ELDN Price Today: Eledon Pharmaceuticals, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Eledon Pharmaceuticals (NASDAQ: ELDN) proposes 450M-share authorization increase - Stock Titan
Eledon Pharmaceuticals (ELDN) Partners with NewcelX to Enhance D - GuruFocus
5 Unstoppable Stocks That Could Double Your Money - Insider Monkey
Here is Why Eledon Pharmaceuticals (ELDN) is an Unstoppable Stock That Could Double Your Money - Insider Monkey
NewcelX Ltd. Enhances Type 1 Diabetes Program with Strategic Collaboration with Eledon Pharmaceuticals - Quiver Quantitative
NewcelX Updates Corporate Presentation to Highlight Type 1 Diabetes Flagship Program Following Strategic Collaboration with Eledon Pharmaceuticals Ahead of Swiss Biotech Conference - marketscreener.com
NewcelX heads to Swiss Biotech with a Type 1 diabetes strategy - Stock Titan
We're Not Very Worried About Eledon Pharmaceuticals' (NASDAQ:ELDN) Cash Burn Rate - Moomoo
symbol__ Stock Quote Price and Forecast - CNN
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Short Interest Down 14.5% in March - MarketBeat
Big Picture: Can Eledon Pharmaceuticals Inc outperform under higher oil pricesWeekly Trade Review & AI Forecast for Swing Trade Picks - baoquankhu1.vn
EPS Watch: Is Eledon Pharmaceuticals Inc backed by strong institutional buyingWeekly Market Outlook & Short-Term Swing Trade Alerts - baoquankhu1.vn
SG Americas Securities LLC Makes New Investment in Eledon Pharmaceuticals, Inc. $ELDN - MarketBeat
Can Eledon Pharmaceuticals (ELDN) Stock Beat the Market | Price at $3.15, Up 3.11%High Conviction Picks - Xã Thanh Hà
Can Eledon Pharmaceuticals Inc expand its profit marginsMarket Movement Recap & Safe Capital Growth Plans - baoquankhu1.vn
Market Review: Can Eledon Pharmaceuticals Inc outperform under higher oil pricesRecession Risk & Reliable Intraday Trade Alerts - baoquankhu1.vn
Gainers Report: What hedge funds are buying Eledon Pharmaceuticals Inc2026 Trade Ideas & Safe Capital Growth Stock Tips - baoquankhu1.vn
After islet transplants, 10 diabetes patients stopped using insulin - Stock Titan
Insider Sell: Can Eledon Pharmaceuticals Inc outperform under higher oil pricesWeekly Stock Report & Technical Buy Zone Confirmations - baoquankhu1.vn
Eledon Pharmaceuticals Inc (2TK.SG) - Yahoo! Finance Canada
ELDN Forecast, Price Target & Analyst Ratings | ELEDON PHARMACEUTICALS INC (NASDAQ:ELDN) - ChartMill
Short Interest in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Rises By 30.3% - marketbeat.com
Geopolitics Watch: What hedge funds are buying Eledon Pharmaceuticals Inc2026 News Drivers & Stepwise Trade Execution Plans - baoquankhu1.vn
Vanguard disaggregates holdings after realignment; Eledon (ELDN) showing 0 shares - Stock Titan
What is Noble Financial's Forecast for ELDN Q1 Earnings? - MarketBeat
Is Eledon Pharmaceuticals (NASDAQ:ELDN) In A Good Position To Deliver On Growth Plans? - Sahm
Midday Stock Roundup: RxSight Climbs 7% - Orange County Business Journal
Eledon Unveils New Type 1 Diabetes Data - Orange County Business Journal
Noble Financial Maintains Eledon Pharmaceuticals(ELDN.US) With Buy Rating, Maintains Target Price $10 - Moomoo
Eledon Pharmaceuticals, Inc.: Fundamental Analysis and Financial Ratings | 2TK | US28617K1016 - marketscreener.com
If You Invested $1,000 in Eledon Pharmaceuticals Inc (ELDN) - Stock Titan
LifeSci Capital Maintains Eledon Pharmaceuticals(ELDN.US) With Buy Rating, Maintains Target Price $4 - Moomoo
Eledon Pharmaceuticals Reports Positive 2025 Results for Tegoprubart in Transplant Trials and Receives FDA Orphan Drug Designation - Minichart
Eledon Pharmaceuticals, Inc. 2026 Annual Report: Business Overview, Risk Factors, and Strategic Focus on Immunology and Tegoprubart Development 29 - Minichart
Eledon Pharmaceuticals (NASDAQ:ELDN) Announces Quarterly Earnings Results, Beats Expectations By $0.10 EPS - MarketBeat
ELEDON PHARMACEUTICALS ($ELDN) Releases Q4 2025 Earnings, Stock Rises - Quiver Quantitative
Eledon Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Operating and Financial Results - The Manila Times
Eledon Pharmaceuticals 2025 net loss widens on higher R&D costs - TradingView
Eledon (NASDAQ: ELDN) 2025 results show higher R&D spend and cash - Stock Titan
Tegoprubart data and new orphan status headline Eledon (NASDAQ: ELDN) 2025 update - Stock Titan
Eledon Pharmaceuticals options imply 11.7% move in share price post-earnings - TipRanks
ELDN PE Ratio & Valuation, Is ELDN Overvalued - Intellectia AI
0.14%
0.48%
大文字化:
|
ボリューム (24 時間):